Press Releases

Wilmington, Del., Oct. 11, 2023 – Ashland is showcasing its recently launched bioresorbable polymers technology platform and two new life sciences products during upcoming tradeshows including CPHI Barcelona, October 24 -26, in booth 5J10; at AAPS PHarmSCi 360 in Orlando, FL, October 22 – 25, booth

Wilmington, Del., October 3, 2023 – As a part of Ashland’s recently announced Super Wetting Agent Technology Platform, the company has launched a portfolio of Easy-Wet ™ substrate wetting agents, a new generation of silicone-free, high-performing oligomeric alkyl polyether polyols for premium

WILMINGTON, Del., Aug. 28, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) has changed the start time of the company’s Innovation Day being held on Tuesday, September 12, 2023. The event will now begin at 9:30 a.m. ET instead of 9:00 a.m. ET for both in-person attendees as well as those

Robin Lampkin named senior vice president, general counsel and secretary WILMINGTON, Del., Aug. 17, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced that its board of directors has approved the appointment of Robin Lampkin as senior vice president, general counsel and secretary.

WILMINGTON, Del., Aug. 14, 2023 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.385 cents per share on the company's common stock. The dividend is payable on September 15, 2023, to stockholders of record at the close of business on

Wilmington, Del., August 2, 2023 - Ashland has launched iSolve ™ pharma, a pharmaceutical customer portal where customers can easily access robust information about the company’s pharmaceutical offerings and other important related business material such as our most recent innovations, literature,

WILMINGTON, Del., July 27, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) will host a live Innovation Day on Tuesday, September 12, 2023 beginning at 9:00 a.m. ET at the company’s corporate headquarters in Wilmington, Delaware. Interested participants must register for the event and have the

  Sales of $546 million, down 15 percent compared to the prior-year quarter Net income (including discontinued operations) of $50 million, or $0.94 per diluted share Income from continuing operations of $42 million, or $0.79 per diluted share Adjusted income from continuing operations excluding

WILMINGTON, Del., July 14, 2023 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its fiscal-third quarter earnings release at approximately 5 p.m. ET on Tuesday, July 25, 2023. The company’s live webcast with securities analysts will include an executive summary and

Registration for limited seating open now   WILMINGTON, Del., July 6, 2023 – Ashland is collaborating with The Pii Center for Pharmaceutical Technology, University of Mississippi School of Pharmacy, to present The Advanced Hands-on Course in Tablet Technology at the Ashland state-of-the-art